Literature DB >> 29635536

Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.

Yasushi Nagata1, Tomoki Kimura1.   

Abstract

Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery (SRS) for intracranial tumors. Since the 1990s, SBRT has been widely used in clinical settings for the treatment of lung cancer. We review the history and current standard techniques. Previous clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are also reviewed.

Entities:  

Mesh：

Year:  2018        PMID： 29635536     DOI： 10.1093/jjco/hyy034

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


  12 in total

1.  Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer.

Authors:  Ichiro Nagata; Takashi Ogino; Takeshi Arimura; Takashi Yoshiura
Journal:  Lung Cancer (Auckl)       Date:  2020-10-09

2.  Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer.

Authors:  Takaya Inagaki; Hiroshi Doi; Naoko Ishida; Aritoshi Ri; Saori Tatsuno; Yutaro Wada; Takuya Uehara; Masahiro Inada; Kiyoshi Nakamatsu; Makoto Hosono; Yasumasa Nishimura
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

3.  Stereotactic body radiotherapy feasibility for patients with peripheral stage I lung cancer and poor pulmonary function.

Authors:  Aiko Koba; Kazuhiko Hayashi; Osamu Suzuki; Yoshifumi Kawaguchi; Kazuhiko Ogawa; Masashi Chatani
Journal:  Oncol Lett       Date:  2020-01-22       Impact factor: 2.967

4.  Stereotactic Body Radiotherapy for Pulmonary Oligometastasis from Colorectal Cancer.

Authors:  Nao Kobayashi; Takanori Abe; Shin-Ei Noda; Y U Kumazaki; Ryuta Hirai; Mitsunobu Igari; Tomomi Aoshika; Satoshi Saito; Yasuhiro Ryuno; Shingo Kato
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 5.  Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors.

Authors:  Dawn Owen; Terence T Sio
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

6.  Verification of rebuild-up effect on superficial cardiac lesion of ventricular tachycardia using 3-D printed phantom in volumetric-modulated arc therapy planning.

Authors:  Shiwon Roh; Jun-Bong Shin; Yong-Ki Bae; Jungmin Kim; Semie Hong; Jeong-Woo Lee
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

Review 7.  Review of Deep Learning Based Automatic Segmentation for Lung Cancer Radiotherapy.

Authors:  Xi Liu; Kai-Wen Li; Ruijie Yang; Li-Sheng Geng
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

8.  Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy.

Authors:  Jian Chen; Jiade J Lu; Ningyi Ma; Jingfang Zhao; Chang Chen; Min Fan; Guoliang Jiang; Jingfang Mao
Journal:  Radiat Oncol       Date:  2019-01-25       Impact factor: 3.481

9.  Identification of novel prognostic factors focusing on clinical outcomes in patients with non-small cell lung cancer after stereotactic body radiotherapy.

Authors:  Hikari Sato; Fumiki Ito; Kazuki Hasegawa; Ryo Saga; Yoichiro Hosokawa; Mitsuki Tanaka; Masahiko Aoki
Journal:  Oncol Lett       Date:  2022-01-11       Impact factor: 2.967

10.  Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.

Authors:  Nathan P Doupnik; Khalid Hirmiz; Abdulkadir A Hussein; John Agapito; Ming Pan
Journal:  Cureus       Date:  2022-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.